ACP
CNCE

Acuta Capital Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Acuta Capital Partners’s Portfolio CNCE Stock Details CNCE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$6.79M Buy
2020
Q3 		$2.95M Buy
2017
Q2 		– Sell
2017
Q1 		$837K Buy